Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Fengtao You
Phase 1 Clinical Trial Demonstrated That MUC1 Positive Metastatic Seminal Vesicle Cancer Can Be Effectively Eradicated by Modified Anti-Muc1 Chimeric Antigen Receptor Transduced T Cells
Science China Life Sciences
Genetics
Molecular Biology
Environmental Science
Biochemistry
Biological Sciences
Agricultural
Related publications
Neuroblastoma and Ewing's Sarcoma Associated With ROR1 Expression Can Be Effectively Targeted With NK Cells Modified to Express an Anti ROR1 Chimeric Antigen Receptor
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Chimeric Antigen Receptor Transduced T Cells - Tuning Up for the Next Generation
International Journal of Cancer
Cancer Research
Oncology
Chimeric Antigen Receptor T-Cells
Cancer Journal
Cancer Research
Oncology
CML Hematopoietic Stem Cells Expressing IL-1RAP Can Be Targeted by Chimeric Antigen Receptor (CAR)-engineered T Cells
Cancer Research
Cancer Research
Oncology
Engineering HIV-Resistant, Anti-Hiv Chimeric Antigen Receptor T Cells
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Effectiveness of Chimeric Antigen Receptor T Cells May Be Impaired by Prior Chemotherapy
Cancer
Cancer Research
Oncology
Novel Bispecific Aptamer Enhances Immune Cytotoxicity Against MUC1-Positive Tumor Cells by MUC1-CD16 Dual Targeting
Molecules
Organic Chemistry
Molecular Medicine
Analytical Chemistry
Theoretical Chemistry
Pharmaceutical Science
Medicine
Drug Discovery
Chemistry
Physical
Cytotoxic Function of Chimeric Antigen Receptor (CAR) T Cells Redirected by Anti-Muci Nanobody
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
Cancer Research
Cancer Research
Oncology
